. Author manuscript; available in PMC: 2017 Jul 19.

Published in final edited form as: J Thorac Cardiovasc Surg. 2016 Sep 19;153(1):118–125.e1. doi: 10.1016/j.jtcvs.2016.09.016

TABLE 5.

Outcomes of control and goal-directed perfusion patients

	Controls (n = 88)	Goal-directed perfusion patients (n = 88)	P value
Incidence of AKI (50% increase from base)	23.9 (21)	9.1 (8)	.008
AKIN 0 (no AKI)	76.1 (67)	90.9 (80)	.03
AKI stage 1 (50%–100% or ≥0.3 increase)	19.3 (17)	5.7 (5)
AKI stage 2 (100%–200% increase)	3.4 (3)	3.4 (3)
AKI stage 3 ( >200% increase or HD)	1 (1.1)	0
Median % Cr increase from baseline (IQR)	27 (11–48)	10 (0–27)	<.001
Only patients with preoperative GFR<90 mL/min (No. of pts)	51	58
Median % Cr increase from baseline (IQR)	22 (8–45)	9 (0–27)	.001
Only patients with preoperative GFR<60 mL/min (No. of pts)	13	20
Median % Cr increase from baseline (IQR)	40 (7–57)	9 (−5 to 28)	.04

AKI, Acute kidney injury; AKIN, Acute Kidney Injury Network; HD, hemodialysis; Cr, creatinine; IQR, interquartile range; GFR, glomerular filtration rate; pts, patients.